Gene · 6175
Papers4,207
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,207
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation. | Bioorg Chem | 2026 | 41666627 | PubTator, text mining | PubMed |
| Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus. | ACR Open Rheumatol | 2026 | 41614297 | PubTator, text mining | PubMed |
| Biallelic PAX7 variants cause a novel Satellite Cell-opathy with progressive muscle involvement resembling facioscapulohumeral muscular dystrophy. | Cell Death Dis | 2026 | 41611663 | PubTator, text mining | PubMed |
| Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma. | J Immunother Cancer | 2026 | 41592893 | PubTator, text mining | PubMed |
| Long non-coding RNA UCA1 modulates SMARCA2-containing SWI/SNF chromatin remodeling complexes in human colorectal cancer. | iScience | 2026 | 41537001 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| c‑Myc‑regulated RPLP0 via the ROS‑mediated JAK2/STAT3 positive feedback loop facilitates hepatocellular carcinoma malignancy progression. | Int J Oncol | 2026 | 41312719 | PubTator, text mining | PubMed |
| A novel TGFβ1-Hs3st2-tau axis regulates tau pathology and synaptic integrity. | Front Neurosci | 2025 | 41810327 | PubTator, text mining | PubMed |
| Identification of endogenous reference genes for RT-qPCR analysis in breast cancer and matched adjacent tissues. | Front Oncol | 2025 | 41640432 | PubTator, text mining | PubMed |
| Editorial: PANoptosis and its role in T cell-based immunotherapy. | Front Immunol | 2025 | 41246316 | PubTator, text mining | PubMed |
| Effects of everolimus on circadian gene expression and cell fate in synchronized Caco-2 cells. | Exp Cell Res | 2025 | 41235964 | PubTator, text mining | PubMed |
| LncRNA RMRP knockdown upregulates PD-1 expression in natural killer cells. | Sci Rep | 2025 | 41044334 | PubTator, text mining | PubMed |
| Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance. | Nat Commun | 2025 | 41006278 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| E2-regulated transcriptome complexity revealed by long-read direct RNA sequencing: from isoform discovery to truncated proteins. | RNA Biol | 2025 | 40965441 | PubTator, text mining | PubMed |
| Engineering Characterization of Small-Scale Bioreactors for Large-Scale hiPSC Production. | Biotechnol J | 2025 | 40899429 | PubTator, text mining | PubMed |
| Donor-dependent regulation of type II and X collagen deposition by early modulation of miR-335-5p and miR-1246 during chondrogenic commitment. | Stem Cell Res Ther | 2025 | 40877986 | PubTator, text mining | PubMed |
| MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines. | Noncoding RNA | 2025 | 40863726 | PubTator, text mining | PubMed |
| Comparison of Primary Human Osteoblast-like Cells and hFOB 1.19 Cells: Contrasting Effects of Proinflammatory Cytokines. | Cells | 2025 | 40862744 | PubTator, text mining | PubMed |
| The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active. | Nat Commun | 2025 | 40855049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6175/papers?page=3